Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Background: Insulin resistance (IR) is a potential predictor of antidepressant treatment response. Aims: We assess changes in IR after antidepressant treatment and whether these changes have any effect on treatment response. Also, to see whether changes in IR mediates relationship between C-reactive protein (CRP) and antidepressant efficacy. Methods: This is a secondary analysis of an 8-week, open-label clinical trial with 95 adults experiencing a major depressive episode. Response to vortioxetine was measured using the Montgomery–Åsberg Depression Rating Scale (MADRS). Generalized estimating equation models were utilized for this intent-to-treat analysis. Results: When adjusted for age, sex, and body mass index, there was a significant increase in IR following treatment in the overall sample (p = 0.035). This finding was detected in treatment non-responders (p = 0.019), whereas it was not observed in responders (p = 0.329). Mediation analysis revealed that change in IR during treatment was responsible for change in MADRS as well as the relationship between baseline CRP and treatment response. Conclusions: Exacerbation of IR during antidepressant treatment mediated non-response. Conversely in treatment responders IR reduced. Like previous studies, baseline CRP moderated treatment response. This relationship was also mediated by changes in IR. These findings further elucidate the role of IR in terms of antidepressant response as well as potentially explain inflammation’s relationship with the latter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2013) · Cited by 44,563
Preacher, K. J., & Hayes, A. F. (2008) · Behavior Research Methods · doi:10.3758/brm.40.3.879 · Cited by 34,117 · cited 1×
“Bootstrapping with 5000 resamples was performed to determine bias-corrected (asymmetric) 95% confidence intervals (CIs) for indirect effects (Preacher and Hayes, 2008).”
MethodCorrect Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program
Levy, J. C., Matthews, D. R., & Hermans, M. P. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2191 · Cited by 2,013 · cited 1×
“IR in the basal state was calculated from fasting insulin and fasting plasma glucose using the HOMA2 calculator (http://www. dtu.ox.ac.uk) (Levy et al., 1998).”
MethodInflammation and clinical response to treatment in depression: A meta-analysis
Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A., & Cleare, A. J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.06.007 · Cited by 666 · cited 1×
“This meta-analysis found significant decreases in tumor necrosis factor-alpha (TNF-α) levels in treatment responders, while TNF-α remained elevated in treatment non-responders (Strawbridge et al., 2015).”
Uher, R., Tansey, K. E., Dew, T., Maier, W., Mors, O., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., Farmer, A., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010094 · Cited by 418 · cited 3×
“(Uher et al., 2014).”
BackgroundInflammatory status and insulin resistance
Grimble, R. F. (2002) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200209000-00015 · Cited by 410 · cited 2×
“It is not surprising that a similar pattern was found in IR, as it has close ties to inflammatory states (Grimble, 2002).”
BackgroundKöhler-Forsberg, O., Buttenschøn, H. N., Tansey, K. E., Maier, W., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., Farmer, A., Rietschel, M., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.02.020 · Cited by 283 · cited 2×
“Baseline CRP levels are associated with more severe depression (Köhler-Forsberg et al., 2017) and treatment resistance (Zhang et al.”
BackgroundChronic Immune Stimulation Correlates with Reduced Phenylalanine Turnover
Neurauter, G., Schrocksnadel, K., Scholl-Burgi, S., Sperner-Unterweger, B., Schubert, C., Ledochowski, M., & Fuchs, D. (2008) · Current Drug Metabolism · doi:10.2174/138920008785821738 · Cited by 274 · cited 1×
“In summary, both IR and CRP are associated with inadequate treatment response, and some of the proposed mechanisms of resistance are the same; both have deleterious effects on monoamines, including serotonin (Jha et al., 2017; Neurauter et al., 2008).”
BackgroundOkamura, F., Tashiro, A., Utumi, A., Imai, T., Suchi, T., Tamura, D., Sato, Y., Suzuki, S., & Hongo, M. (2000) · Metabolism · doi:10.1053/meta.2000.9515 · Cited by 241 · cited 1×
“Okamura et al. (2000) detected an improvement in IR following successful treatment of depression with tricyclic antidepressants.”
BackgroundJha, M. K., Minhajuddin, A., Gadad, B. S., Greer, T., Grannemann, B., Soyombo, A., Mayes, T. L., Rush, A. J., & Trivedi, M. H. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.01.023 · Cited by 206 · cited 3×
“Email: houman.rashidian@uhn.ca serotonin, and its ability to enter the brain are impaired (Jha et al., 2017).”
Background
Cited by
McIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836
Self-citationHuang, C., You, H., Zhang, Y., Li, Z., Li, M., Feng, X., & Shao, N. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06336-4 · Cited by 78
Consolidating evidence on the role of insulin resistance in major depressive disorder
Krupa, A. J., Dudek, D., & Siwek, M. (2023) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000905 · Cited by 47
Insulin resistance: The role in comorbid type 2 diabetes mellitus and depression
Yao, J., Zhu, C., Sun, Y., Huang, Y., Li, Q., Liao, H.-M., Deng, X.-J., & Li, W.-M. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106218 · Cited by 50
Impact of Antidepressants on Weight Gain: Underlying Mechanisms and Mitigation Strategies
Mouawad, M., Nabipur, L., & Agrawal, D. K. (2025) · Archives of Clinical and Biomedical Research · doi:10.26502/acbr.50170450 · Cited by 39
“Prior research has shown that CRP may serve as a predictor of antidepressant response [96,97].”
Metadata
- Authors
- Rashidian, H., Subramaniapillai, M., Park, C., Lipsitz, O., Zuckerman, H., Cao, B., Lee, Y., Gill, H., Rodrigues, R. N., Di Vincenzo, J. D., Iacobucci, M., Jaberi, S., Rosenblat, J. D., McIntyre, R. S., & Mansur, R. B.
- Affiliations
- University Health Network (CA)
- Southwest University (CN)
- Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario
- Corresponding author
- Rashidian, Houman
- ORCID
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2022-11-15
- Volume
- 37
- Issue
- 3
- Pages
- 313-317
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- PMC
- PMC10076336
- OpenAlex
- W4309099433
- Cited by
- 23
- References
- 24
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 10 · 2023: 3
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Psychopharmacology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Brain and Cognition Discovery Foundation by Lundbeck, Denmark
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- insulin resistance, antidepressant response, major depressive disorder, vortioxetine, C-reactive protein, inflammation, mediation analysis, treatment non-responders
- MeSH terms
- Vortioxetine, Adult, Antidepressive Agents, C-Reactive Protein, Depressive Disorder, Major, Major Depressive Disorder, Double-Blind Method, Humans, Insulin Resistance, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder. https://app.cochat.ai/papers/10.1177/02698811221132473
- The paper
- Rashidian, H., Subramaniapillai, M., Park, C., Lipsitz, O., Zuckerman, H., Cao, B., Lee, Y., Gill, H., Rodrigues, R. N., Di Vincenzo, J. D., Iacobucci, M., Jaberi, S., Rosenblat, J. D., McIntyre, R. S., & Mansur, R. B. (2023). Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder. Journal of Psychopharmacology. https://doi.org/10.1177/02698811221132473
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.